Who
Margaret Pax
Director
Company insider
Files Form 4 as: Director, Repligen; Director, Alimera Sciences.
In numbers
- Trades disclosed
- 14
- Buys
- 1
- Sells
- 0
- Bought
- $38K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 7 Nov 2023
- Last trade
- 14 May 2026
- Last filed
- 18 May 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 18 May 2026 | RGEN RepligenBiotechnology | SEC FORM 4 Code A | —995 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | RGEN Repligenoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,239 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | RGEN Repligenoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,239 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | RGEN RepligenBiotechnology | SEC FORM 4 Code A | —995 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | RGEN Repligenoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,800 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | RGEN RepligenBiotechnology | SEC FORM 4 Code A | —973 at $0.00 | filing |
| 17 Mar 2025filed 18 Mar 2025 | RGEN RepligenBiotechnology | SEC FORM 4 Bought | $38K250 at $150.69 | filing |
| 16 Sep 2024filed 18 Sep 2024 | Alimera Sciencesoption or derivative | SEC FORM 4 Code D | —36,713 | filing |
| 16 May 2024filed 20 May 2024 | RGEN Repligenoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,376 at $0.00 | filing |
| 16 May 2024filed 20 May 2024 | RGEN RepligenBiotechnology | SEC FORM 4 Code A | —701 at $0.00 | filing |
| 18 Mar 2024filed 19 Mar 2024 | RGEN Repligenoption or derivative · Biotechnology | SEC FORM 4 Code A | —195 at $0.00 | filing |
| 18 Mar 2024filed 19 Mar 2024 | RGEN Repligenoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,236 at $0.00 | filing |
| 18 Mar 2024filed 19 Mar 2024 | RGEN RepligenBiotechnology | SEC FORM 4 Code A | —92 at $0.00 | filing |
| 7 Nov 2023filed 8 Nov 2023 | Alimera Sciencesoption or derivative | SEC FORM 4 Code A | —36,713 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.